Mental Health Clinics in Claxton, GA Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Tippin Bank & Trust Company Counselor - Pastoral Medicare: Not Enrolled in Medicare Practice Location: 409 Oak St, Claxton, GA 30417 Phone: 912-739-1122 |
O'bear & Associates Behavior Services Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1213 Perkins Mill Rd, Claxton, GA 30417 Phone: 773-757-4074 |
Evans Memorial Hospital, Inc. Hospital Units - Psychiatric Unit Medicare: Not Enrolled in Medicare Practice Location: 200 N River St, Claxton, GA 30417 Phone: 912-739-2611 Fax: 912-739-5101 |
News Archive
CardioNet to acquire Biotel
CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.
Researchers integrate meditation and science to develop targeted mental health treatments
Mindfulness is always personal and often spiritual, but the meditation experience does not have to be subjective. Advances in methodology are allowing researchers to integrate mindfulness experiences with brain imaging and neural signal data to form testable hypotheses about the science - and the reported mental health benefits - of the practice.
Efforts to 'fix' Medicare payments at center of reform
The Wall Street Journal reports: "A plan to end a program that would cut government payments to doctors is emerging as the flash point in the debate over whether President Barack Obama's effort to overhaul the health system would increase the federal budget deficit.
BerGenBio completes $8.8M Series A financing round
BerGenBio AS, an emerging oncology biopharma company, today announced it has completed an $8.8 million Series A financing round. The financing will be used primarily to take lead compound BGB324 into clinical trials and to develop a companion diagnostic.
› Verified 5 days ago